The global japanese encephalitis (JE) vaccine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Japanese encephalitis (JE) is a viral brain infection that is caused by the Japanese encephalitis virus (JEV) which is carried mostly by mosquitos and causes swelling of the brain. Additionally, it leads to significant mortality and neurological problems in infected individuals. The major factor for the growth of the market is the rising incidence of JE across the globe.
According to the United Nations Children’s Fund (UNICEF), JE is the leading cause of viral encephalitis which primarily affects children, in Asia and the Western Pacific. Additionally, it is endemic in 24 countries with an estimated 3 billion people at risk. Furthermore, an estimated 70,000 clinical cases a year are caused due to JE out of which up to 30-50% of cases are at the risk of developing permanent neurologic or psychiatric sequelae with a fatality rate that can reach up to 30%, resulting in between 13,600 to 20,400 mortality. Moreover, 50% of JE cases in some countries occurrs in adults. Hence, the increasing incidence of JE is driving the demand for JE vaccines for treatment, which in turn is driving the growth of the market during the forecast period.
To Request a Sample of our Report on Japanese Encephalitis (JE) Vaccine Market: https://www.omrglobal.com/request-sample/japanese-encephalitis-je-vaccine-market
Some major players in the market include Sanofi SA, GlaxoSmithKline plc, and Novartis International AG, among others. Furthermore, government initiatives to prevent the disease is boosting the growth of the market. For inctamce, in October 2021, the Assam government launched an immunisation drive against Japanese encephalitis (JE) for the 15-65 age group while targeting to cover 40.17 lakh people.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Sanofi SA, GlaxoSmithKline plc, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Japanese Encephalitis (JE) Vaccine Market is Available @ https://www.omrglobal.com/industry-reports/japanese-encephalitis-je-vaccine-market
Global Japanese Encephalitis (JE) Vaccine Market Report by Segment
By Type
- Inactivated Vaccines
- Recombinant Vaccines
- Live Attenuated Vaccines
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
Global Japanese Encephalitis (JE) Vaccine Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
